海创药业(688302.SH)：上半年净亏损1.48亿元

格隆汇8月29日丨海创药业(688302.SH)公布2022年半年度报告，报告期归属于上市公司股东的净利润-1.48亿元；归属于上市公司股东的扣除非经常性损益的净利润-1.64亿元；基本每股收益为-1.74元。

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.